An Overview of One Health Concept Focusing on Toxoplasmosis
PDF
Cite
Share
Request
Review
P: 256-274
December 2023

An Overview of One Health Concept Focusing on Toxoplasmosis

Turkiye Parazitol Derg 2023;47(4):256-274
1. Erciyes University Faculty of Veterinary Medicine, Department of Parasitology, Kayseri, Türkiye
2. Independent University, School of Environment and Life Sciences, Department of Life Sciences, Dakka, Bangladesh
3. Turkish Public Health Institution, National Parasitology Laboratory, Department of Microbiology Reference Laboratories, Ankara, Türkiye
4. Erciyes University Faculty of Medicine, Department of Medical Parasitology, Kayseri, Türkiye
No information available.
No information available
Received Date: 23.08.2023
Accepted Date: 20.11.2023
Publish Date: 26.12.2023
PDF
Cite
Share
Request

ABSTRACT

The "One Health" concept is a universal approach to sustainably balancing and optimizing the health of humans, animals, and ecosystems. This approach is based on the health of humans, domestic and wild animals, and plants in a wider environment in which self-renewable ecosystems exist, with essential characteristics of integration, unifying and holistic perspective. Toxoplasmosis, one of the most common zoonotic infections in both terrestrial and oceanic ecosystems in the world, is an ideal model disease for the “One Health” approach. Toxoplasmosis is a zoonotic disease caused by the obligate intracellular pathogen protozoan Toxoplasma gondii. In the life cycle of T. gondii, the definitive host is domestic cats and felines, and the intermediate hosts are all mammals (including humans), birds and reptiles. The infected cats have primary importance and play a crucial role in the contamination of habitats in the ecosystems with T. gondii oocysts. Thus, ecosystems with domestic cats and stray cats are contaminated with cat feces infected with T. gondii oocytes. T. gondii positivity has been scientifically demonstrated in all warm-blooded animals in terrestrial and aquatic habitats. The disease causes deaths and abortions in farm animals, resulting in great economic losses. However, the disease causes great problems in humans, especially pregnant women. During pregnancy, it may have effects such as congenital infections, lesions in the eye and brain of the fetus, premature birth, intrauterine growth retardation, fever, pneumonia, thrombocytopenia, ocular lesions, encephalitis, and abortion. The mechanism of death and abortion of the fetus in a pregnant woman infected with T. gondii occurs as a result of complete disruption of the maternal immune mechanism. The struggle against toxoplasmosis requires the universal collaboration and coordination of the World Organization for Animal Health, the World Health Organization and the World Food Organization in the "One Health" concept and integrative approaches of all responsible disciplines. Establishing universal environmental safety with the prevention and control of toxoplasmosis requires the annihilation of the feces of the infected cats using suitable techniques firstly. Then routinely, the monitoring and treatment of T. gondii positivity in cats, avoiding contact with contaminated foods and materials, and development of modern treatment and vaccine options. Particularly, mandatory monitoring or screening of T. gondii positivity during the pregnancy period in humans should be done. It would be beneficial to replace the French model, especially in the monitoring of disease in humans. In this article, the ecology of toxoplasmosis was reviewed at the base of the "One Health" concept.

Keywords: One health, ecology of toxoplasmosis, Toxoplasma gondii, pregnancy, prevention and control, interdisciplinary, struggle

INTRODUCTION

Pathogens like viruses, bacteria, parasites, fungi, and prions, pose significant threats to humans, animals, and plants, often leading to outbreaks of a wide variety of diseases with emerging and reemerging features (1,2) of which 75% are classified as reemerging zoonotic infections (3). The Outbreaks have appeared as sporadic, endemic, epidemic and pandemic in the history of epidemiology (2). Throughout history, humans facing adverse natural conditions and infectious diseases have been engaged in a continuous battle against these outbreaks. This ongoing battle has evolved into the modern “One Health” concept, which represents a significant step forward. International organizations such as the World Health Organization (WHO), the World Organization for Animal Health (OIE), and the Food and Agriculture Organization of the UN (FAO) coordinate the implementation of the "One Health" approach, with global-scale strategies developed to address these challenges. As a result, many zoonotic epidemics and pandemics have been effectively controlled. Toxoplasmosis is a zoonotic disease caused by the coccidian parasite Toxoplasma gondii. Cats have special importance in the ecology and epidemiology of toxoplasmosis, as they act as both final and intermediate hosts in the life cycle of T. gondii. This pathogen can be seen in all animals including the intermediate host human, mammals, poultry, and reptiles and causes abortions in intermediate mammalian hosts, with sheep being highly susceptible resulting in significant economic losses. Therefore, it is necessary to evaluate toxoplasmosis in the context of “environmental health, animal health and human health in a self-renewing ecosystem” with a holistic perspective. To effectively address toxoplasmosis, it is crucial to develop combat strategies and programs that involve all relevant stakeholders in a coordinated effort. However, before taking action, it is important to first analyze the connection between the ecosystem and toxoplasmosis from a human-centric perspective. Throughout human history, the interest to understand and control nature has always been high to mitigate increasing animal protein and energy demands destroying natural ecosystems including the oceans. Therefore, new holistic approaches should employed within the scope of the slogan “stop ecocide” and “to create self-renewing ecosystems on land and in the ocean, to produce healthy animals and functional animal products on the basis of herd health, and to reach safe food, healthy and happy people”. In this context, the motto "One World, One Health" concept was developed by WHO.

The Chronological Development of the “One Health” Concept in Historical Periods

Although the concept of “One Health” was officially introduced in the early 2000s, its roots can be traced back to ancient times, as far back as the discovery of fire. Archaeologists have described the discovery of fire by humans as a complex process that took place over a long period. Although the discovery of fire is about 1.5 million years ago, its use with flint dates back to 400,000 years ago. However, the third phase, in which people use fire regularly, goes back to about 7,000 years ago (4). The fact that humans heat food with fire and then consume especially cooked animal products has generated the beginning of a new era for human nutrition (5). The domestication of cattle in the Neolithic Age around 14,000 years ago was another turning point in human history, as it led to the selective breeding of farm animals and the regular production and consumption of animal-based foods such as meat and milk. To protect human health, the consumption of animal products that have died from infectious diseases or are suspected to have died from such diseases has been abandoned. Therefore, humans have taken measures to prevent diseases of animal origin and protect their interests (6-8).

Following that, about 12,000 years ago, the cultivation of wheat and the initiation of agriculture became a new historical period in human nutrition. The consumption of agricultural products has also been an important step for human health. Additionally, humans utilized agricultural practices to generate animal feed, resulting in healthier livestock and better-quality animal products. The consumption of foods from animal and plant sources provided the “adaptation to food and the formation of intestinal flora” in the gastrointestinal tract of humans. This evolutionary adaptation has increased the resistance against food-borne diseases, so that people have been healthier and happier. This selective eating habit has continued until today (5,8). The period of human history that witnessed the transition to settled city life marked a crucial epoch in terms of health. Roughly 10,000 years ago, humans established communal city life, beginning with the earliest settlements such as Göbekli Tepe and Çatalhöyük in the “fertile crescent” region. This development had an important impact on the establishment of public health. Around 9,500 years ago, city people began to domesticate cats as a means of combating pests like mice in their immediate surroundings. This practice was the beginning of the “environmental sanitation period” in areas where people lived, which played a crucial role in maintaining good health (9).

The concept of “One Health” was based on scientific observations during the period of the Greek philosopher Hippocrates (460-370 BC). Hippocrates in his book titled “On Airs, Waters and Place” mentioned the necessity of “Air, Water and Soil” for optimum health and wrote the first information about “Environmental Health/Eco Health” (10). Over time, the concept of “One Health” has flourished through the acquisition of knowledge about diseases in the context of historical processes. In the Neolithic period, the relationships between arthropods such as flies, fleas, lice, and ticks and the diseases observed in humans and animals were noticed (11). Recently, archaeoentomology has focused on investigating ancient civilizations and their environments, particularly ancient human communities, with an emphasis on pest insects, preserved products, and mummies (12-17). In history, various Anatolian civilizations (eg; Ephesus, Hittite) have been destroyed by vectors (such as mosquitoes, ticks, fleas) and various vector-borne diseases including malaria, plague, Crimean Congo haemorrhagic fever, etc. (18). In the early stages of history, primarily plague pandemics (first: 541-750 in Egypt, the Middle East, Northern Europe; second: 1331-1855 in Central Asia and Europe; third: 1855-1960 in China, India, and the West Coast of the United States) were seen. At the same periods of history, it has been considered that the causes of many epidemic/pandemic diseases are microorganisms. However, since the microscope was not invented yet during the first and second Plague Pandemics, pathogens causing the disease could not be shown (19).

Ibn Sina, also known as Avicenna (980-1037) is renowned as one of the most notable Turkish philosophers in history. His influential work, “The Canon of Medicine” or “The Law of Medicine,” included various aspects of medical knowledge. Within this extensive book, Ibn Sina provided a significant contribution to the field of epidemiology by defining the concept of the Plague and presenting an insightful approach to understanding disease transmission (20). In his book “The Canon of Medicine”, Sina explored different aspects of medical science. The first treatise explored anatomy, while the second focused on the causes and symptoms of diseases. The third treatise incorporates topics such as hygiene, health, sickness, the inevitability of death, and the implementation of quarantine measures to prevent and control outbreaks (21). Giovanni Maria Lancisi, an Italian philosopher (1654 to 1720), was a prominent epidemiologist who researched how the physical environment contributes to the transmission of diseases among humans and animals (Figure 1).

Figure 1

With the invention of the microscope by Antonie van Leeuwenhoek (1632-1723), a new historical period called the “Microscopic Era” started. During this time, significant progress has been made in the field of pathogen diagnosis for human and animal diseases, disease identification, and the implementation of infection control strategies. Soon after this historical development, the world’s first veterinary school was established by Claude Bourgelat in Lyon, France in 1762 (22). At the beginning of the 19th century, German Pathologist Rudolf Virchow (1821-1902) emphasized the importance of the strong link between human medicine and veterinary medicine and laid the foundation of the concept of “One Health” in the modern sense. Dr. Virchow used the term “Zoonosis/disease transmitted from animal to human” for the first time and demonstrated the importance of zoonotic pathogens and diseases with zoonotic characters with the famous phrase “There is no dividing line between animal and human medicine - there should not be” (23). The discovery of the Rabis vaccine in 1885 by Louis Pasteur was a step forward toward the “One Health” concept (24). Later, Sir William Osler (1849-1919) emphasized that similar thinking methods are required in both veterinary medicine and human medicine for optimal health in his work titled “Principles and Practice of Medicine” (25). In 1854, at a meeting of the London Epidemiological Society, John Snow presented two groundbreaking maps displaying the cholera epidemic and visually illustrating the spread of the disease. A few months later, Snow’s maps were published in his book “On the Mode of Communication of Cholera.” Nobel Prize-winning German physician Heinrich Hermann Robert Koch (1843-1910) successfully isolated the pathogens responsible for anthrax (1877), tuberculosis (1882) and cholera (1883) bacilli and also developed the “Koch Postulates”. Dr. Koch has displayed very important scientific contributions to the concept of “One Health,” both etiologically and epidemiologically (26). On the other hand, Scottish Medical Doctor Sir Patrick Manson (1844-1922) discovered the transmission of a human parasite (Wuchereria bancrofti) through mosquitoes in 1877. In the field of epidemiology, Dr. Manson made a significant contribution by describing a vector-borne disease for the first time which also contributed to the "One Health" concept. In addition, Dr. Manson proposed the theory that “Malaria Can Be Transmitted by Mosquitoes” which further advanced our understanding of how diseases can be transmitted (27). Victor Babes, a Romanian scientist discovered Babesia bovis in 1888, a parasite with zoonotic characteristics than Veterinary surgeon Curtis, along with his colleagues Theobald Smith and Fred Kilborne, identified a blood parasite in bovine erythrocytes and named the disease “Texas Fever” caused by Pyrosome bigeminum opened a new era in the epidemiology of tick-borne diseases (28). Soon after in 1897, Dr. Sir Ronald Ross (1857-1932) proved Dr. Manson’s hypothesis that “Malaria may be a vector-borne disease” and discovered that Malaria was transmitted by mosquitoes. Thus, malaria took its place in the history of epidemiology as a mosquito-borne disease. These historical discoveries have ensured great scientific contributions to the “One Health” concept (29). The discovery of the BCG vaccine by two French Veterinary Surgeon and Bacteriologist Jean Marie Camile GUERIN and Albert CALMETTE was a significant advancement in the battle against epidemics, particularly tuberculosis (30).

Their invention in the 1920s made a tremendous contribution to the “One Health” concept, highlighting the interconnections between human and animal health. During the early stages of urban life and culture, advancements in city infrastructure such as “Sanitization” and “Modern Urbanization” studies, which date back to the bronze age (3000-1100 BC) and began with “Urban Hydrological Technologies,” led to significant gains in the fight against contagious diseases. The establishment of public drinking water supply systems and sewer systems to carry off waste matter were revolutionary chronological developments that contributed to the “One Health” concept (31,32). Furthermore, works such as coagulation, flocculation, sedimentation, filtration (including microfiltration and ultrafiltration systems), and disinfection were essential in preventing aquatic pathogens and water-borne diseases, and legal standards were eventually established to guarantee these processes. The establishment of treatment units in the sewerage networks, the determination of standards, and the fact that they are guaranteed by legal regulations have also created revolutionary positive developments for “One Health” in terms of environmental, animal, and human health. In this context, John Laing Leal (1858-1914) disinfected drinking water by chlorinating it in 1908 in Jersey City, New Jersey (33)
(Figure 2).

Figure 2

The “antibiotic age” brought about significant advancements in the fight against infectious diseases through the use of antibiotics, resulting in a new historical development period for the “One Health” concept. Alexander Fleming also explained in 1949 the fact that the wrong usage of antibiotics can lead to “Antimicrobial Resistance (AMR)”. As an indicator of the fight against antimicrobial resistance, the European Veterinary Federation (FVE) initiated and conducted the Healthy Livestock project against AMR in 1975 (34). Subsequently, with the discovery of dichloro-diphenyl-trichloroethane, a highly toxic and persistent insecticide, by Swiss chemist Paul Hermann Müller (1899-1965), who was later awarded the Nobel Prize in Medicine, a new era began in the fight against pests and vector-borne diseases in 1939. However, shortly after, due to the excessive harmful effects of this chemical, its use was banned in 1970, which is highly significant from a “One Health” perspective (35). As an indication of this, the FVE launched the AMR and Healthy Livestock project in 1975 to combat AMR and provide education on it (36). Through this project, significant contributions were made to the interdisciplinary development of the “One Health” concept by regulating the use of antimicrobials in Veterinary Medicine. Contemporary Veterinarian Epidemiologist/parasitologist Calvin Schwabe (1927-2006) wrote a book titled “Veterinary Medicine and Human Health” in 1964 where he proposed “One Medicine Concept as Unified Approach to Human and Veterinary Health,” particularly cooperation between Human Physicians and Veterinary Surgeons for the Control of Zoonotic diseases. In the book for the first time, Schwabe declared veterinary surgeons as the primer responsible professional of the “One Health” concept. With Schwabe’s modern and up-to-date approach, the professionals involved in the interdisciplinary cooperation of the “One Health” concept have been clearly pointed out (37). Toxoplasma gondii is a zoonotic apicomplexan protozoan parasite, and it serves as a prime example of a modern approach to "One Health" practices. In the 1970s, Prof. Dr. Jitender Prakash Dubey, a veterinarian and parasitologist, identified T. gondii and conducted research on its life cycle, epidemiology, and ecology. His work has contributed to the formation of multidisciplinary collaborations between the fields of veterinary medicine and human medicine, which is essential to the "One Health" concept (38). In fact, since the mid-1900s, the collaboration between veterinary and human medicine has continued to strengthen worldwide, and similar cooperation examples have been observed in Turkey. In the Ottoman Institute of Bacteriology in İstanbul, Veterinarian Adil Mustafa Şehzadebaşı and French Medical Doctor Microbiologist Maurice Nicolle made a significant discovery in 1902, demonstrating that the Rinderpest virus could pass through filters. In 1915, Dr. Reşat Rıza Kor, developed the typhus vaccine at the Bacteriology Center in Istanbul, and it was first administered by Dr. İbrahim Refik Saydam (39). In 1929, Veterinary Ord. Prof. Dr. Süreyya Tahsin Aygün developed the “Universal Anthrax Vaccine,” while in 1933, Veterinarian Captain Kemal Cemil and Prof. Dr. René Legroux collaborated on vaccine research at the Paris Pasteur Institute, resulting in the development of the “Anamorve” vaccine (40).

Simultaneously with these historical achievements of the "One Health" concept, it was realized that the relationship between diseases and environment is very important. American Environmental Microbiologist Dr. Rita Rossi Cowell (1934-) has worked on global waterborne infectious diseases and their impacts on global health with the perspective of “Climate and Global Distribution of Microorganisms”. Her unique perspective has made a significant impact on the advancement of "One Health", particularly regarding the epidemiology of Vibrio cholerae, a pathogen that resides in aquatic environments and causes Cholera disease (41). The “resistance” of parasites to some chemicals used as pesticides, acaricides, and insecticides led to prohibitions that marked an important and historical beginning in the "One Health" approach to prevent ecological contamination. Unfortunately, despite these chemical bans, systems developed to meet increasing energy demands, such as nuclear power plants, coal-based thermal power plants, deep energy in oceans, and hydroelectric generation systems (HEPP) on rivers, cause serious ecocidal effects on ecosystems. These devastating situations lead to major environmental disasters in both terrestrial and marine systems, posing serious threats to human and animal health (42).

The solution to these global environmental problems lies in the “One Health” approach, which involves international collaborations using strong early warning systems and developing sustainable alternative energy sources. New approaches have been developed in the control and prevention of diseases due to the advancement and studies in the field of immunology. In 1996, Nobel Prize-winning Australian veterinarian Peter Charles Doherty (1940) and Swiss immunologist Rolf Martin Zinkernagel discovered “the mechanism of the immune system to recognize virus-infected cells,” making a significant contribution to the concept of “One Health” (43).

The establishment of international organizations and their coordinated work have brought significant advantages in the control of diseases on a global scale. Some examples of international centers established chronologically include: the Food and Drug Administration in 1906, the League of Nations in 1920, the OIE in 1924, the FAO in 1943, the UN in 1945, the WHO in 1945, the United Nations International Children’s Emergency Fund (UNICEF) in 1946, the Center for Disease Control and Prevention (CDC) in 1946, the United Nations (UN) Environment Program (UNEP) in 1972, the European Medicines Agency (EMA) in 1995, the European Food Safety Authority (EFSA) in 2002, the European Center for Disease Control (ECDC) in 2004, and the Institute of One Health (IOHR) in 2022 (Figure 3).

Figure 3

The joint work of veterinarians and human physicians has progressed significantly since the establishment of the Veterinary Public Health unit at CDC by Doctor Veterinarian James H. Steele in 1947 (35). Important studies for "One Health" have also been conducted in the following periods. The Manhattan Principles about “One World, One Health” (2004) have been an important development in terms of "One Health", as they focus on issues such as combating epizootic/epidemic diseases and developing holistic approaches such as protecting basic biodiversity and ecosystem integrity (44).  Nobel Prize-winning American biologist and parasitologist William C. Campbell (1930) discovered a new therapy against Nematode infections in 2012 (45). Veterinary Parasitologist, Sir/Lord Prof. Dr. Ernest Jackson Lawson Soulsby (1926-2017) made significant contributions to institutionalizing the “One Health” approach. In honor of Sir Soulsby for his devoted work, The Soulsby Foundation was established in 2016 to internationally support research and other charitable activities related to promoting the “One Health” approach between the Medical and Veterinary professions (46).  The historical progress of the concept of “One Health” has essentially been closely related to world politics. After the collapse of the Soviet Union in 1992, a new era has begun. In 1994, the concept of “Globalization” was developed and applied in almost every field (eg “Global Economy”, and “Global Trade”). In this context, WHO has also developed the concept of “Global Health”. However, this approach left its place in the “One Health” concept in the early 2000s. Soon after, in 2002, WHO developed the slogan “One World One Health”. The World Organization for Animal Health (OIE) also defined in 2020 the concept of “One Health” as “Ecosystem Health” (47).

In the modern era, cooperation and joint work between Epidemiologists and Virologist Veterinarians and Human Physicians, especially their coordinated work in the Scientific Committees established for special purposes, have provided important gains in the fight against epidemic diseases. In the global fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19), a zoonotic virus that caused a pandemic, strategies have been developed to combat the disease. This pandemic is the latest epidemic encountered in the history of humanity, and its economic losses cannot be calculated. The WHO announced the pandemic in March 2020. Human physicians, veterinarians, epidemiologists, virologists, public health specialists, and all health professionals have worked selflessly and coordinated at the highest level to combat the disease. Their work is the greatest example and achievement of the “One Health” concept.

In the Covid-19 pandemic, vaccines developed with “Subunit Vaccine Technology” reached the development of the “One Health” concept to the new age. During this process, the development of vaccines against Covid-19 by both human physicians and veterinarians and their widespread use in immunizing people have been historical successes in terms of "One Health". Turkish scientists have greatly contributed to the “One Health” concept by showing great success in the global fight against Covid-19. The inventors of the BIONTECH vaccine are Medical Doctors Prof. Dr. Uğur Şahin and his wife Prof. Dr. Özlem Türeci and the inventor of the TURKOVAC vaccine, Veterinarian Prof. Dr. Aykut Özdarendeli’s contributions have been highly recognized. Also, the Crimean-Congo Vaccine was developed by Özdarendeli constitutes another important model study in terms of "One Health". 

On October 17, 2022, the FAO, the UNEP, the WHO, and the OIE launched a new five-year (2022-2027) One Health Joint Action Plan. The plan outlines six steps to be taken to achieve its objectives.

These actions:

1. Developing "One Health" capacities to strengthen health systems.

2. Reducing the risk of emerging and re-emerging zoonotic outbreaks and pandemics.

3. Control and eradication of endemic zoonoses, tropical epidemics and vector-borne diseases.

4. Evaluation, management and reinforcement of food safety risks.

5. To curb the silent epidemic of AMR.

6. Integrating the Environment into "One Health" (48) (Figure 4).

Figure 4

In order to achieve sustainable goals in the "One Health" concept, scientific excellence, dissemination of knowledge, interdisciplinary coordinated management, creation of needed funds and advanced monitoring systems integrated with an early warning system are required.  In addition to these, primary professional responsible veterinarians must establish strong collaborations with other responsible stakeholders, especially human physicians, in the development of sustainable alternative approaches, uncompromising biosecurity practices, and the preservation of ecological connections between habitats and integrity assurance. Ensuring the participation of the public in this cooperation will provide great convenience in obtaining successful results. In order to better understand the “One Health” concept developed in the New Millennium and to achieve the necessary gains for professionals to fulfill their responsibilities, this concept should be given as a “Compulsory Lesson” and “Course Information Packages” in the “National Core Curriculum” of faculties Veterinary, Medical, Dentistry, Pharmacy and Health Science. In addition, the UNESCO Eco Health/Environmental Health initiative supported the protection of the sea and oceans and the creation of the necessary culture for this with the slogan “One Earth-One Ocean (OEOO) (49). In Turkey, “Veterinary Public Health Departments” were established in Veterinary Medicine Faculties within the scope of the Council of Higher Education, UNESCO/ISCED Education Standard Classification. This development meets an important need and is very beneficial in creating an academic infrastructure for rapidly acquiring the “One Health” culture in higher education. The next step in developing the “One Health” approach, as seen in the United States and Europe, is to integrate “One Health” into the curricula of relevant higher education units. Today, in accordance with the "One Health" concept, the epidemiology of zoonotic infections is mainly evaluated together with their ecological factors and dynamics of the causative pathogens with enzootic characteristics. In this context, it is necessary to examine the ecology of T. gondii, which causes toxoplasmosis, one of the most common parasitic infectious diseases in the world.

Epidemiology and Ecology of Toxoplasma gondii

Since cat act as both intermediate and final hosts in the life cycle of T. gondii, the ecosystem consistently gets contaminated with their infected feces. There is a close relationship between the contamination of ecosystems with T. gondii oocysts and the number of infected cats in a region. When the population of domestic cats in an area is higher than that of stray cats, the potential of contamination of ecosystems with T. gondii also increases. In the USA, a large number of domestic cats carry T. gondii throughout their lifecycle and each infected cat can release millions of oocysts. Epidemiological studies revealed that domestic cats are more likely to contaminate the environment than stray cats (50-53). It is important to note that T. gondii oocysts can remain infective for months or years in harsh natural conditions making it more difficult to control (51-54). It has been estimated that on the Morro coast of California in the United States, domestic and stray cats excrete approximately 77.6 and 30 tons of feces per year, leading to environmental contamination of over 4,500 oocysts/m2 per year (55). The increase in the number of cats will increase the possibility of contamination of the environment with T. gondii oocysts increasing the likelihood of intermediate hosts such as humans, domestic animals, and wild animals getting infected with T. gondii oocytes, which in turn increases the likelihood of final host cats becoming infected. The inability to clearly understand the role of domestic cats in the spread of toxoplasmosis and the epidemiology of the disease in many ecosystems, and sometimes ignoring this critical situation, constitutes an important handicap in informing society accurately and adequately (56).

Animal care-feeding policies can have an impact on the number of stray cats and the risk of transmission of T. gondii by removing cats from open places (31,32). With a growing number of animal shelters, deliberate outdoor housing of cats will reduce the risk of transmission of T. gondii to humans, pets and wildlife (56). Determining the concentration of T. gondii oocysts in the environment is critical for assessing health risks in a holistic framework. Research showed that land, water and ocean can be contaminated with T. gondii and the survival of oocysts in soil may vary depending on geological and environmental characteristics such as soil temperature, texture and chemistry. Under optimal conditions, oocysts can survive for approximately four years (57-60). Factors such as the presence of water or humidity, cold temperatures (not freezing), and sufficient oxygen are essential for their longevity (61). To model the spread of oocysts in the soil to wider environments, it is important to consider factors such as the effect of rainwater, land use, and cat density. However, the environmental parameters responsible for the long-term infectivity of oocysts, their resistance, the extent of environmental contamination, and the survival time or infectivity of cysts following the intermediate host’s death are not fully understood. The omnipresence of T. gondii oocysts and the ability to rapidly sporulate under suitable environmental conditions also increase the likelihood of infection for all at-risk species in the ecosystem (62).

The prevalence of T. gondii in some countries with very cold or hot climates tends to be lower in humans, while in countries with warm and humid climates is higher.  In general, the prevalence of T. gondii infection appears to be higher in temperate regions of the world. The prevalence of the disease in humans has been reported to be 8-22% in the United States, with similar rates in the United Kingdom, and 30-90% in Central America, South America and Continental Europe (63-69). In Turkey, the seroprevalence of T. gondii in humans is 10-85% and the highest rate is in the Southeastern Anatolia Region; In a study conducted in Ankara, immunglobulin (Ig)G and IgM positivity were found to be 22.3% and 0.64%, respectively. 47% of women between the ages of 15-45 who came to Turkey from Syria and were likely to become pregnant were found to be T. gondii positive (70,71). 

It has been reported that more than one million people are infected each year in the USA and approximately 2,839 people develop “ocular toxoplasmosis” annually. The economic loss caused by the disease is estimated to be approximately 3 billion USD. Salmonella, Listeria, and T. gondii are jointly responsible for more than 75% of food-related deaths in the United States (72); Scallan et al. (73) reported that T. gondii causes 8% of food-borne hospitalizations and 24% of deaths in the US. Although there are no routine screening programs for toxoplasmosis in the US, Canada, the Netherlands, Norway and England, all pregnant women are subject to screening programs in countries such as France, Belgium, Italy, Switzerland, Germany and Austria. In these countries, serological testing is mandatory every month or every three months to detect a possible new infection earlier if the screening results are negative (Table 1).

Table 1

The biggest challenge in the diagnosis of toxoplasmosis is the detection of acute infection and its differentiation from chronic infection. Detection of Toxoplasma infection can be made using serological tests (IgM and/or IgG), ultrasound scans (suspicious images) and amniocentesis. Since maternal infection does not always result in fetal death, it is important to determine the presence of fetal infection. Congenital toxoplasmosis can be detected in the fetus by using polymerase chain reaction for T. gondii DNA in amniotic fluid (70,74,75). Infections occurring in early pregnancy have minimal risk of fetal transmission (less than 6%). However, transmission rates in the third trimester can increase as much as 60% and 81% (76).

The One Health concept, with the slogan “One World, One Health,” takes a holistic view of human, animal, plant, and environmental health at the local, global, and even space levels. In this context, if the historical development of toxoplasmosis, the transmission routes of the agent and its effects are known in all aspects, the disease can be better understood. In particular, it is encouraged to implement the necessary coordinated cooperation between professionals such as universities, state institutions (especially local governments), non-governmental organizations, politicians, doctors and veterinarians, and the public, to protect ecosystem health.

Discovery and Definition Processes of Toxoplasma gondii

Toxoplasma gondii was first discovered in 1908 by Nicolle and Manceaux in the tissues of Ctenodactylus gundi, a hamster-like rodent used in leishmaniasis research in Charles Nicolle’s laboratory at the Pasteur Institute in Tunisia (77).
The scientists first thought the parasite was a pyroplasm, but later realized that it was a newly discovered microorganism.
This new microorganism was named “Toxoplasma gondii” by Nicolle because of the morphological characteristics of the parasite and the host being Ctenodactylus gundi. However, later comments were made that this nomenclature was not made correctly and that the correct name of the parasite should be “Toxoplasma gundii”. It has been suggested that the basis of these critical comments was related to mistakenly naming the host of the parasite as “Ctenodactylus gondi” instead of “Ctenodactylus gundi” (51,52). In the same year, Splendore (78) discovered the same parasite in a rabbit in Brazil and mistakenly identified it as Leishmania but did not name it as a species (79). About 30 years later, it has been suggested that organisms similar to T. gondii were found in other hosts, particularly in some bird species. Sabin and Olitsky (80) investigated the cause of unexpected encephalomyelitis while conducting a study on viruses in mice. They showed that this encephalitis was not caused by a virus and that the main cause was T. gondii. In the following years, Sabin and Feldman (81) found that humoral antibodies killed extracellular tachyzoites but not intracellular tachyzoites. In the next 50 years, it has been determined that protective immunity is largely mediated by lymphoid cells. On the other hand, in the pyrophosphate homeostasis of T. gondii, pyrophosphate-dependent phosphofructokinase plays a crucial role in regulating pyrophosphate levels, ensuring a balanced metabolism between breaking down and building up molecules. This allows the parasite to effectively utilize carbon nutrients obtained from host cells, enhancing its ability to thrive as a parasite. Additionally, pyrophosphate-dependent phosphofructokinase is vital for the parasite’s growth and virulence in living organisms, while being absent in human hosts, presenting an opportunity for targeted drug development to treat toxoplasmosis (82).

Three dominant archetypal clonal lineages of T. gondii have been identified to date (83-86). Various atypical genotypes have also been found in America and China (87-89). Although there is no dominant genotype in the southern hemisphere, some genotypes are dominant in the northern hemisphere, notably genotypes 1 (type II clonal), 2 (type III) and 3 (type II variant) that make up the majority of isolates in Europe. Genotype 2 and Genotype 5 (both Genotype 4 and Genotype 5 are known as Genotype 12) are common in North America. Genotype 2 is dominant in Africa with Genotype 3 outside of North America; Genotype 9 and Genotype 10 are quite common in China (89-91). Some genotypes have been associated with increased virulence in humans and wildlife (92-95). Lorenzi et al. (96) compared the genomes of 62 isolates of conserved large haploblocks with different ancestral origins worldwide that may affect the spread, host range and pathogenicity of T. gondii. Among the clonal lineages, Lineage 1 to Lineage 4 were found to be the most widespread with very similar multilocus genotypes, high levels of linkage disequilibrium, and sparse recombination features.

The first study about toxoplasmosis in animals in Turkey was carried out by Akçay and colleagues (97,98). Later, Ekmen and Altıntaş (99), isolated T. gondii from a new borne kid with hydrocephaly for the first time. Yucesan et al. (100) inoculated the isolated strain of T. gondii in albino mice. The whole genome of this T. gondii strain was studied for the first time and registered in the NCBI database as T. gondii TR01.

Toxoplasmosis in Humans

In recent studies, it has been shown that the main way of the spread of T. gondii is the contamination of the ecosystem with oocysts. Some of the primary and critical factors that increase the risk of human and animal infection include consuming meat that is raw or undercooked and infected with pathogens, disposing of cat feces contaminated with oocysts into sewage systems which can spread the disease to water bodies, drinking water that contains oocysts, eating vegetables grown in soil that is contaminated, or coming into contact with anything else that is contaminated with oocysts. Other means of transmission include receiving blood or organ transplants, being infected via intrauterine or transplacental transmission, or drinking unpasteurized milk that has been infected with the pathogen (103,107-110). Toxoplasmosis is the second leading cause of death among foodborne diseases in the USA. In humans, the presence or absence of symptoms at the time of infection does not provide information about whether the disease will occur later in life. The disease can be seen in individuals of all ages and can show an acute or chronic course (111-114). T. gondii infection after birth can have an asymptomatic course or it can affect other organs including the eyes causing fever and lymphadenopathy (115-118). The virulence of the disease varies depending on the individual’s genetic characteristics, susceptibility, and the strain of the parasite (119). For example, it has been suggested that T. gondii genotypes found in French Guiana cause significant damage and even death in adult humans who are not immunocompromised (94). Reports suggest higher virulence in South American toxoplasma strains compared to strains from Europe and North America, leading to more severe ocular toxoplasmosis and acquired toxoplasmosis cases (120). It has been reported that an estimated 1.1 million people in the USA are infected with T. gondii each year and approximately 10.4% of the population is exposed to the parasite (121,122). The infection may cross the placenta and reach the fetus if the mother is infected during pregnancy, and it can proliferate in fetal tissues (123). In a congenital toxoplasmosis case, the infection may also induce lesions in the eyes and brain of the fetus or systemic pathological findings such as premature birth, intrauterine growth retardation, fever, pneumonia, and thrombocytopenia (124,125). Ocular lesions or signs of encephalitis in the fetus may include chorioretinitis, meningoencephalitis, hydrocephalus, microcephaly, or calcifications of necrosed areas; infants usually do not show clinical signs at birth, but deafness may occur later in life. If exposure to infection in pregnant women occurs after the first 6 months of pregnancy, the rate of transmission of the infection to the fetus is considerably reduced. The diagnosis of congenital toxoplasmosis can be made by serological tests which are the commonly used methods. Although toxoplasmosis is a treatable disease and transplacental transmission can be prevented by Spiramycin treatment, prevention is the best solution to combat T. gondii. It is important to note that Spiramycin cannot reverse the damage if the parasite has already passed the placenta and/or infection has induced any damage to the fetus (123). Latent and primary toxoplasmosis, as well as diseases that can be treated with corticosteroids, cytotoxic drugs, and tumor necrosis factor alpha antibody, can be particularly dangerous for individuals with compromised immune systems (125,126). Encephalitis develops in approximately one-third of individuals infected with both T. gondii and HIV (127). Regulatory T-cells (Treg) are very important in the maternal immune mechanism in pregnant women and abnormal pregnancy outcomes are mainly associated with Treg dysfunction (128-130). In addition to the regulatory functions of Tregs, the effects of the transcriptional factor Foxp3, which has a critical role, and the role of proinflammatory cytokines such as Macrophage Migration Inhibitory Factor (MIF) are also essential. During T. gondii infection, the pathogen may invade the placental tissue and impair maternal-fetal immune tolerance. This immune-pathological issue can cause maternal immune rejection, affect fetal growth, and lead to miscarriage and/or other pregnancy complications (131). Adverse pregnancy outcomes are associated with reduced Treg cell counts by apoptosis triggered by T. gondii infection (132). However, different susceptibility to T. gondii infection may occur during the first and third trimesters of pregnancy due to variations in MIF regulation. Such sensitivities have an important role in the initiation of the inflammatory response that may result in abortion and the activation of immunologic patterns. MIF, which triggers the activation of extracellular signal regulated-kinase (ERK1/2) and prostaglandin E2 (PGE2) by participating in the immune response against T. gondii, is an effective cytokine in pregnancy. This cytokine plays a major role in the inflammatory response and defense against the pathogen. Therefore, death and abortion in a pregnancy infected with T. gondii occur as a result of the complete disruption of the maternal immune mechanism (130,132).

Retinal toxoplasmosis is considered to be the leading cause of blindness in many parts of the World (133,134). It has been reported that ocular toxoplasmosis develops in approximately 5,000 people per year in the USA (122). Exposure to T. gondii has been associated with mental decline and overall increased disease symptoms in the elderly (135). In addition, T. gondii is associated with many neuropsychiatric disorders including anxiety, suicide attempts, depression, and schizophrenia (109,136-139). Although the mechanisms defining these relationships are not known for certain, they may be related to the immune response to tissue cysts and the presence of bradyzoite tissue cysts in the brain post-infection (111). In one study, T. gondii oocyst-specific IgG antibodies were found in 193/490 (43%) pregnant women’s serum samples whereas in another study positive cases were found in 30 out of 340 (8.8%) samples in pigs. Twenty-four (80%) of these T. gondii positive 30 samples also gave oocyst-derived IgG positivity. The results of these serological studies also confirmed that the infection started with the ingestion of T. gondii oocysts (140,141). Oocysts of T. gondii can also be found in drinking water sources such as both small-scale wells and larger water reservoirs as well as removing hairs of pet animals (dog hair) or machines used for shaving dogs, etc. It has been suggested that it can also contaminate the surfaces of equipment (142–145). For all these reasons, the high risk of spreading and transmission of oocysts should be considered and should never be neglected.

Toxoplasma gondii in Pets and Farm Animals

Despite its high prevalence worldwide, toxoplasmosis in domestic cats cannot be distinguished clinically or asymptomatically. Among the clinical symptoms fever, ocular inflammation, anorexia, lethargy, pneumonia, abdominal pain, and discomfort in the central nervous system could be observed (52,111). Although clinical T. gondii infection is severe in domestic cats, it has been suggested that wild cats are at higher risk of infection than domestic cats (146). Pet dogs can also be infected with T. gondii. However, subclinical infection in dogs is more common than clinical infection (147,148). Respiratory, neuromuscular or gastrointestinal systems are affected by the disease in infected dogs, and clinical signs and even death may occur (147). Although free-range dogs are believed to be at higher risk, pet dogs can acquire T. gondii parasites from infected meat that is given uncooked or raw (149).

Common intermediate hosts for toxoplasmosis are sheep, goats, pigs and chickens. Cattle and horses are particularly resistant to the disease. The primary effect of congenital infection in sheep is the loss of offspring due to premature birth or stillbirth. Lambs born alive but infected usually show normal growth. However, if the infected meat of these animals is consumed, there is a risk to public health (147).

Abortion, stillbirth, weak offspring, and nonspecific clinical signs such as fever, loss of appetite, and weight loss are observed in small ruminants, pigs, and occasionally other livestock. The incubation period of toxoplasmosis is usually a few days until nonspecific clinical signs appear, and it can take days or weeks until abortion or stillbirth occurs. Definitive hosts, such as cats, usually do not display clinical signs, except for rare cases of diarrhea. Toxoplasmosis can also be seen in adult goats, and it is more severe compared to sheep. In goats, the congenital infection also results in the loss of offspring before or after birth (150). During both acute and chronic infections, tachyzoites can be transmitted through milk, including goat milk, as well as sheep and cattle milk. Drinking unpasteurized goat’s milk has been identified as a risk factor for human infection in epidemiological surveys (151,152). Pigs can become infected with T. gondii by ingestion of infective oocysts through water and food, by transplacental passage of tachyzoites, and by ingestion of infected meat with T. gondii bradyzoite tissue cysts. Although adult pigs infected with T. gondii rarely show clinical signs, the meat of these infected pigs is a potential source of infection for humans. Young pigs infected with T. gondii can die from toxoplasmosis before they can enter the food chain for humans. Toxoplasmosis positivity is largely due to contamination of the environment with oocysts of the parasite. Free-roaming domestic cats have been identified as the major risk factor in the infection of farm animals (150). As a result, livestock shelters and facilities, which lack adequate biosecurity, pest and pest management practices, do not implement regular screening and control programs, and whose environment is not restricted, constitute important risk factors for animal infection (53,110).

Toxoplasmosis has been classified as a notifiable disease in certain countries as part of their efforts to prevent and control its spread. The disease is present in all types of animals in countries such as Latvia, Poland, and Switzerland, and Finland. In Germany, only certain animals, including pigs, dogs, and cats, are required to be reported if they carry the disease. On the other hand, in Austria, Denmark, Sweden and Turkey, notification is not obligatory. It is necessary to make standard regulations in this regard and to make reporting mandatory in all countries (153) (Table 2).

Table 2

Toxoplasma gondii in Wild Animals

The transmission route of T. gondii in wild animals can be counted as ingestion of infected felines or their organ/tissue remains, consumption of infected intermediate host, ingestion of sporulated oocysts directly from the contaminated environment or transplacental transmission of tachyzoites from infected female to offspring. Transmission of T. gondii to carnivores and omnivores such as polar bears (Ursus maritimus), grizzly bears (Ursus arctos) and black bears (Ursus americanus) may occur through environmental contamination, predation of infected hosts and consumption of their meat or direct ingestion of sporulated infective oocysts (154,155).

The geographic and taxonomic prevalence of infection in marine mammals is explained by the transport of oocysts from land to sea, primarily by rainwater and sewage waters (160-163). Infection of the endangered southern sea otter (Enhydra lutris nereis) with T. gondii is associated with the land-to-sea transport of infected domestic or wild cat feces (164-166). Unfortunately, this transmission route, which is completely contrary to the normal mechanism of the ecosystem, has also been confirmed for other marine mammals (166,167). Similar genotypes of T. gondii have been detected in tissues from sea otters, terrestrial wildlife animals such as lynx, mountain lions, wild canids, and wild domestic cats sharing the California coast (156,168,169). Shapiro et al. (165) showed that invisible polymers play a critical role in the transmission of T. gondii in food webs through particle aggregates and biofilms, also increase parasite retention in snails grazing on algae, and facilitate infection of sea otters. At land-to-sea coastal exposure, phocids, otariids, mustelids, and some threatened and endangered marine mammals are also affected (170-176). However, data on T. gondii positivity from cetacean deaths are limited compared to those obtained through autopsies of terrestrial animals.

Protection and Control Practices

Fecal samples of domestic cats should be periodically monitored for T. gondii oocyst positivity. It should also be ensured that these cats do not hunt mice and birds. Domestic cats should not be given uncooked meat or giblets (177). To ensure effective biosecurity measures during tasks such as changing cat litter at home, it is essential to wear gloves as a preventive measure against potential contamination. It is especially important for pregnant women or for those preparing for pregnancy to be more meticulous in this process (178). In any case, the litter used by the cat to defecate should be kept in a microwave oven at 75 °C so that possible T. gondii oocysts are destroyed. Then it should be disposed of following the medical waste category and procedure (179). The same control practices should be carried out with high precaution in shelters where cats are kept in groups in the municipality-responsible areas. Sand areas of children’s playgrounds, where stray cats are likely to defecate should also be subjected to the same process periodically (53). It is believed that these disciplinary control practices will significantly reduce the contamination of the environment and ecosystem with T. gondii oocysts.  If a cat is diagnosed positive for T. gondii oocyst either by microscopic examination of the stool sample or by advanced laboratory methods, it should be treated with Spiramycin. In addition, post-treatment status should be monitored. At this point, to protect and guarantee the integrity of Animal Health/Public Health/Ecosystem Health with a holistic perspective, diagnosis and treatment expenses of cats in the fight against T. gondii should be evaluated within the National Health Program and government subvention should be provided for necessary expenses. Effective management of T. gondii contamination within the ecosystem can be achieved through the collaborative, disciplined and diligent efforts of all parties involved in the control initiatives led by municipalities (180). This will ensure that the potential impact of T. gondii oocysts on the environment is minimized to a significant degree that ultimately resulting in herd health in animals, community health in humans (eliminating the disadvantage of T. gondii positivity in organ, bone marrow and blood transfusions) and ecosystem health (181). On the other hand, contact between animals, especially felines and rodents, must be prevented. Vaccination of livestock against T. gondii at a young age can be effective in preventing the formation of tissue cysts if they become infected later in life. This preventive measure can help reduce the risk of human exposure to T. gondii through the consumption of infected meat. At the same time, routine analyzes should be performed to monitor the presence of T. gondii in meat or meat products (182). In addition, meat and giblets type foods should be consumed after they have been sufficiently cooked. For this purpose, cooking or smoking at 72-74 oC or freezing at -20 oC will neutralize the bradyzoites in meat cysts. It is very important to wash hands thoroughly after touching raw meat and vegetables (183). Another factor that should be considered is that the cutting boards, containers and tools that the raw food comes into contact with should be washed with soapy water. The food given to cats must be cooked and only dry or canned foods are suggested. Water resources have also played a very important role in the transmission of T. gondii. Therefore, the mixing of water sources contaminated with infected cat feces into drinking water should be prevented and adequate and effective measures should be taken. Especially in rural areas, old and expired water tanks should be renewed and careful sanitation should be done at regular intervals (179). To prevent “water-borne T. gondii transmission,” it is advisable to utilize control methods similar to those employed in the epidemiology and ecology of Tularemia. While working with the soil, it is necessary to use gloves and to wash hands with soap and water immediately after gardening to prevent any possibility of contamination of infected soil with cat feces (184). In this way, the potential risk of contamination can be prevented. Trespassing of cats in the warehouses where the food of butchery animals is stored and contamination of the food with cat feces should be prevented and feed storage areas should be protected following biosecurity rules. One of the important areas that can cause contamination is animal slaughterhouses. Utmost care should be taken to ensure that the giblets of animals slaughtered in slaughterhouses and infected with T. gondii are not thrown into the environment or given to animals uncontrollably after slaughter. Organs and tissues that cannot be consumed as a result of slaughter in slaughterhouses should be destroyed by cremation. In this way, a possible slaughterhouse toxoplasmosis contamination is prevented.

Vaccination and New Treatment Options

In the fight against Toxoplasmosis, it is very important to obtain strong immunity through vaccination. Developing a vaccine that can be used in final or intermediate host animals and providing immunization with vaccination will also constitute one of the most effective solutions for protection and control against toxoplasmosis. Currently, a vaccine containing tachyzoites of T. gondii S48 strain has been developed to prevent abortions caused by toxoplasmosis in sheep and goats. It has been reported that this vaccine, which can be found in Europe and New Zealand, reduces fetal damage but does not prevent fetal infections, and sheep vaccinated with S48 strain can remain immune for at least 18 months (182). This live vaccine poses a risk to pregnant animals. Therefore, it is recommended to apply at least 3 weeks before mating. Pregnant sheep should not be vaccinated. Breeding lambs are vaccinated with the basic vaccine when they are 4-5 months old. It should be noted that the basic vaccine should be administered as a single dose at least 4 weeks before mating. It is recommended that the vaccine booster be administered after 2 years, at least 3 weeks before mating (185). It has also been reported that immunity against T. gondii is formed in mice and rats immunized using T. gondii recombinant tachyzoite antigens and plasmid DNA encoding tachyzoite antigens (186,187).

There is currently no preventive vaccination program against toxoplasmosis in Türkiye. The Parasitology Department at Erciyes University’s Faculty of Veterinary Medicine is conducting a research project on the development of an exosome-based vaccine candidate for toxoplasmosis. The vaccine is produced using tachyzoites grown in BeWo cell cultures, which are derived from human placenta choriocarcinoma. The study has yielded promising preliminary outcomes (188). In addition to these developments, it is considered that new methods and new options can be produced in the treatment of toxoplasmosis in light of the information produced by molecular techniques. In this context, in a study conducted at Erciyes University Faculty of Medicine, Department of Parasitology, it was proven that “Nitroflurane inhibits T. gondii infection by affecting genes in the Toll-Like Receptor pathway”. With this new treatment option, the possibility of developing new preparations with fewer side effects as an alternative method in the treatment of the disease has been considered a promising development (189). In light of these studies, the possibility of producing an effective vaccine and/or vaccine candidates, drug and/or drug candidates for the future in the fight against toxoplasmosis raises hope.

Planning One Health Intervention

One Health approach focuses on interdisciplinary collaborations to solve problems related to animal, human, environmental, and plant health (190). According to One Health concept, effective monitoring of the prevalence of T. gondii has great importance. In the USA, toxoplasmosis is not a nationally notifiable disease. Therefore, its exact prevalence is not known (64,65,191). For the same reason, although the prevalence of toxoplasmosis is very high in other countries such as Brazil, the incidence of congenital disease in children can only be put forward hypothetically (192). Toxoplasmosis screening in pregnant women and newborns is available in the US. However, these congenital toxoplasmosis screening programs lag behind regular screenings in many countries (74). In addition, screening programs for congenital toxoplasmosis alone may miss a large part of the infected population. Therefore, it is important to apply “Advanced Integrated Toxoplasmosis Screening Programs” in the fight against this disease. Advanced Toxoplasmosis Screening Programs will generate more data in reducing risks and developing more sensitive tools. Integrating human, pet and wildlife data allows for better assessment of risk and better control methods. On the other hand, regional and global interaction can further facilitate the local, regional and global spread of pathogens by affecting endangered animal populations. Human-induced environmental changes, travel, globalization and trade may facilitate the spread of T. gondii in human populations, as well as other zoonotic animal parasites. Given that majority of human infectious diseases are of animal origin (zoonotic), it is clear that there is a need to integrate human-animal-ecosystem health within a common framework. This holistic approach has essentially emerged as a basic necessity. Increasing global problems, including environmental change, loss of biodiversity, fragmentation of habitat and the emergence of infectious diseases, and the convergence of the global great danger day by day, require integrative approaches that go beyond the disciplinary boundaries of the “One Health” concept. In this integration, it is suggested that not only governmental institutions, universities and other institutions take part, but also new tasks should be given to them in the creation of new international organizations (177,193,194).

Interdisciplinary Collaborations

Simple solutions are rarely seen in addressing regional or global ecological and environmental problems. A versatile, interdisciplinary "One Health" approach is required in the ecology of infectious diseases. The "One Health" approach can also be applied against Toxoplasmosis as it has been applied during wildlife parasitic zoonosis surveillance in Australia (195) and/or studies of Echinococcus spp in North America (196), and Sri Lanka (197). "One Health" approach was also implemented against some foodborne parasitic diseases caused by Cryptosporidium spp., Giardia duodenalis, Cyclospora cayetanensis and T. gondii in other developed countries (195).

In the last 10 years, new tools and institutional initiatives have been developed to evaluate and monitor emerging pathogens. In this context, knowledge of ecosystems existing in nature, epidemiology of diseases, ecological modeling of disease and web-based analytics have emerged. New types of integrated ecological health assessment are implemented; these include certain biomedical diagnostic tools and environmental indicator studies. Other innovations include the development of non-invasive physiological and behavioral monitoring techniques for the conditions of low-income countries, the adaptation of modern molecular biological and biomedical techniques, the design of population-level disease monitoring strategies, and the creation of ecosystem-based health and preventive species surveillance approaches (198).

Mathematical modeling, predictive tools, and new prevention strategies for emerging infectious diseases have evolved tremendously over the past decade. These exciting tools now enable advanced detection and diagnosis of diseases and disease symptoms (153,177,199)

A data-based decision-support tool should be created to help physicians, experts, and managers for action and intervention. Veterinarians, Physicians, Epidemiologists, geographic modelers, public health officials, and sociobiologists must collectively choose the right model to implement a rigorous approach to etiological agents in disease epidemiology (198).

It is known that T. gondii is affected by environmental conditions and measures to reduce exposure also positively affect ecosystem health. The environmental parameters responsible for the long-term survival and resistance of the parasite in the oocyst form, or the survival as well as the infectivity of tissue cysts from an infected animal that has died in the wild, are not fully understood. The "One Health" approach is also critical to filling such knowledge gaps. For this purpose, joint studies of professionals from a wide range of disciplines have been proposed (200).

Integrative Studies

In addition to the occurrence of acute infection, congenital infection and some other important negative health problems due to toxoplasmosis in humans, it has been suggested that there is a close relationship between the increased number of fatal traffic accidents and T. gondii positivity in recent years (201,202). In the epidemiology of toxoplasmosis, several investigations including surveys are needed to assess risk and to integrate data by developing control methods. Environmental contamination rather than meat consumption has been shown to be a more common and important route for infection epidemiologically (81,149,147,150). Therefore, to understand the risk of transmission, land use and outdoor cat management policies need to be expanded, developed and modeled. At this point, the relations between the Animal Shelter Policies of local governments and the increase in the number of stray cats and the resulting oocyst loads should be considered as basic issues and solutions should be developed in this regard. For this purpose, research can be done with integrative project studies. For example, platforms can be created where interdisciplinary teams can perform field and laboratory studies, spatial, geographical and other mathematical modeling, and integrated applications of veterinary medicine and human medicine. Considering that 1/3 of the world’s population is T. gondii positive, legislation and/or regulatory arrangements for risk reduction and increasing demands for food safety require rapid diagnosis of T. gondii infections. For this purpose, it has been emphasized that there is an urgent need for the development and standardization of safe diagnostic tests with rapid results (203). Such tests need to be previously performed with comparable specificity and sensitivity experiments in a range of animal species to provide an accurate estimate of the risks of transmission of toxoplasmosis to humans. Most farm animals naturally infected with T. gondii (with the exception of suspected beef) have been shown to carry bradyzoites in their meat (204). Chopped or minced meat can be contaminated by mixing other types of meat during these processes. Thus, the epidemiological link between raw beef consumption and outbreaks of T. gondii infection can be explained by such process contamination (64). The relationship between raw meat consumption and toxoplasmosis has been reported in Korea, the USA, France, French Guiana, and New Zealand (203). In these countries, effective screening processes are applied to meat offered to consumers, along with new standard tests that may be useful for the control of T. gondii positivity. Especially at the point of monitoring and control of the disease, it is necessary to carry out such practices effectively throughout the world (205).

Conclusion

The “One Health” concept, which started with the widespread use of fire in the history of modern humans, has reached its current level as a result of its continuous development. Today, the level of “One Health” concept has evolved to the level of “Safe Food”, which is produced with the principle of the “Functional Animal Product Production” process, especially based on “Healthy Food” and defined with the characteristics of “Functional Food”, personalized and compatible with the immune mechanism of the person. On this basis, the "One Health" concept emphasized the necessity of establishing a solid and absolute organic bridge between disciplines connecting human health, animal health and ecosystem health. In this context, the fight against toxoplasmosis requires integrative approaches that transcend the boundaries of disciplines. This integration is for managing and controlling disease and creating new approaches. Identifying the complexity of Toxoplasmosis prevention and management requires the development of a quick and easy reference control panel system, a combination of health and ecological markers. Interdisciplinary, integrative research and capacity building are key elements in the creation of "One Health" interventions for toxoplasmosis. Innovative methodologies that make information flow between stakeholders feasible must address this major challenge facing society, wildlife and ecosystems globally in a consensus and sustainable manner (177). The "One Health" approach to the epidemiology and control of toxoplasmosis requires practical, sustainable and effective solutions with a precise understanding of local socioeconomic and cultural factors, as well as a solid understanding of local, regional, national and international health and environmental policies. The "One Health" approach offers great opportunities for professionals who practice “Environmental Health - Animal Health - Human Health” holism to provide “Concurrent Benefits”. Ultimately for the health of both terrestrial and ocean ecosystems regarding toxoplasmosis, the first step is eliminating the feces of infected cats using appropriate techniques. Secondly, regular monitoring and treatment of T. gondii positivity in cats is a necessity. Additionally, contact with contaminated food and materials should be avoided. Advances in modern treatment and vaccine options should be continued. Mandatory monitoring or screening for T. gondii positivity in humans during pregnancy is essential, particularly the implementation of the French model for human disease monitoring may provide positive outcomes.

Peer-review: Internally peer reviewed.

Authorship Contributions

Concept: A.İ., S.U., G.K.K., Design: A.İ., S.U., G.K.K., A.D.K., Data Collection or Processing: A.İ., S.U., G.K.K., A.D.K., M.M.H.S., Analysis or Interpretation: A.İ., S.U., G.K.K., Ö.D., A.Y., Literature Search: A.İ., S.U., G.K.K., A.D.K., M.M.H.S., M.Y., C.B., Writing: A.İ., S.U., G.K.K., A.D.K.,

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: It was reported by the authors that they did not receive any financial support.

References

1
Aksoy S. Transgenesis and the management of vector-borne disease. Preface. Adv Exp Med Biol 2008; 627: vii-viii.
2
İnci A, Doğanay M, Özdarendeli A, Düzlü Ö, Yıldırım A. Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats. Turkiye Parazitol Derg 2018; 42: 39-80.
3
Tong C. Y. W. Tutorial topics in infection for the combined infection training programme. Oxford University Press; USA: 2019.
4
Scott AC. Burning Planet: The Story of Fire Through Time. Oxford University Press; 2018.
5
Kaplan Y, Yurdugül S. Evrimsel Gastronomi. Güncel Tur Araştırmaları Derg 2018; 2: 582-8.
6
Zhang K, Lenstra JA, Zhang S, Liu W, Liu J. Evolution and domestication of the Bovini species. Anim Genet 2020; 51: 637-57.
7
Clark JD, Harris JWK. Fire and its roles in early hominid lifeways. Afr Archaeol Rev 1985; 3: 3-27.
8
Hu Y, Hu S, Wang W, Wu X, Marshall FB, Chen X, et al. Earliest evidence for commensal processes of cat domestication. Proc Natl Acad Sci U S A 2014; 111: 116-20.
9
Knitter D, Braun R, Clare L, Nykamp M, Schütt B. Göbekli Tepe: A Brief Description of the Environmental Development in the Surroundings of the UNESCO World Heritage Site. Land 2019; 8: 1-16.
10
MILLER G. “Airs, waters, and places” in history. J Hist Med Allied Sci 1962; 17: 129-40.
11
Carter R, Mendis KN. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev 2002; 15: 564-94.
12
Mumcuoglu YK, Zias J. Head lice, Pediculus humanus capitis (Anoplura: Pediculidae) from hair combs excavated in Israel and dated from the first century B.C. to the eighth century A.D. J Med Entomol 1988; 25: 545-7.
13
Mumcuoglu KY, Zias J, Tarshis M, Lavi M, Stiebel GD. Body louse remains found in textiles excavated at Masada, Israel. J Med Entomol 2003; 40: 585-7.
14
Mumcuoglu, Kosta Y. “Human lice: pediculus and pthirus.” Paleomicrobiology, eds D. Raoult and M. Drancourt. Berlin: Springer; 2008: 215-22.
15
Mumcuoglu K, Hadas G. Head Louse (Pediculus humanus capitis) Remains in a Louse Comb from the Roman Period Excavated in the Dead Sea Region. Isr Explor J 2011; 61: 223-9.
16
Boutellis A, Drali R, Rivera MA, Mumcuoglu KY, Raoult D. Evidence of sympatry of clade a and clade B head lice in a pre-Columbian Chilean mummy from Camarones. PLoS One 2013; 8: e76818.
17
Drali R, Mumcuoglu KY, Yesilyurt G, Raoult D. Studies of Ancient Lice Reveal Unsuspected Past Migrations of Vectors. Am J Trop Med Hyg 2015; 93: 623-5.
18
Inci A, Yildirim A, Duzlu O, Doganay M, Aksoy S. Tick-Borne Diseases in Turkey: A Review Based on One Health Perspective. PLoS Negl Trop Dis 2016; 10: e0005021.
19
Jullien S, Dissanayake HA, Chaplin M. Rapid diagnostic tests for plague. Cochrane Database Syst Rev 2020; 6: CD013459.
20
Pajević A, Pajević I, Jakovljević M, Hasanović M, Kravić N, Žigić N. Ibn Sina (Avicenna) as a Psychiatrist: A View from Today’s Perspective. Psychiatr Danub. 2021; 33(Suppl 4): 1218-26.
21
Saffari M, Pakpour AH. Avicenna’s Canon of Medicine: a look at health, public health, and environmental sanitation. Arch Iran Med 2012; 15: 785-9.
22
Degueurce C. Claude Bourgelat et la création des écoles vétérinaires [Claude Bourgelat and the creation of the first veterinary schools]. C R Biol 2012; 335: 334-42.
23
Kahn LH, Kaplan B, Monath TP, Steele JH. Teaching “one medicine, one health”. Am J Med 2008; 121: 169-70.
24
Cavaillon JM, Legout S. Louis Pasteur: Between Myth and Reality. Biomolecules. 2022; 12: 596.
25
Osler W. The principles and practice of medicine: designed for the use of practitioners and students of medicine. D. Appleton; 1902.
26
Wiśniewski J. M., Bielecki J. E., Robert Koch (1843-1910), „Kosmos”, t. 59, 2010, s. 21-23.
27
Chernin E. Sir Patrick Manson’s studies on the transmission and biology of filariasis. Rev Infect Dis 1983; 5: 148-66.
28
Assadian O, Stanek G. Theobald Smith--the discoverer of ticks as vectors of disease. Wien Klin Wochenschr 2002; 114: 479-81.
29
Yoeli M. Sir Ronald Ross and the evolution of malaria research. Bull N Y Acad Med 1973; 49: 722-35.
30
Santiago AR. Jean-Marie Camille Guérin. Rev Soc Venez Microbiol 2001; 21: 94-5.
31
Kerim A, Süme V. İstanbul’un Eski Su Kaynakları; Sarnıçlar. Türk Hidrolik Derg 2018; 2: 1-8.
32
Ortloff CR. The Water Supply and Distribution System of the Nabataean City of Petra (Jordan), 300 bc– ad 300. Camb Archaeol J 2005; 15: 93-109.
33
Klohmann CA, Padilla-Gamiño JL. Pathogen Filtration: An Untapped Ecosystem Service. Front Mar Sci 2022; 9: 921451
34
Droog S, Fleming A. Commentary on “Penicillin”. 1945. J R Nav Med Serv 2015; 101: 31-4.
35
Schultz MG. In memoriam: James Harlan Steele (1913-2013). Emerg Infect Dis 2014; 20: 514-5.
36
Tackling antimicrobial resistance (AMR) HealthyLivestock project – FVE – Federation of Veterinarians of Europe. https://fve.org/publications/tackling-antimicrobial-resistance-amr-healthylivestock-project/
37
Schwabe CW. History of the scientific relationships of veterinary public health. Rev Sci Tech 1991; 10: 933-49.
38
Dubey JP. The history of Toxoplasma gondii--the first 100 years. J Eukaryot Microbiol 2008; 55: 467-75.
39
Hakkımızda. https://vetkontrol.tarimorman.gov.tr/pendik/Menu/5/Hakkimizda
40
Dinçer F. Ord. Prof. Dr. Süreyya Tahsin Aygün’ün Hayatı ve Bilimsel Çalışmaları. Ankara Üniversitesi Veteriner Fakültesi Dergisi 1982; 29: 250-76.
41
Sutek K. Rok 1948 nagroda dla Paula Hermanna Müllera za odkrycie silnego owadobójczego działania DDT [Nobel prize for Paul Hermann Müller in 1948 for discovery of DDT insecticide]. Wiad Lek 1968; 21: 1698.
42
Sánchez-Bayo F. Ecological impacts of insecticides. Insectic-Adv Integr Pest Manag. 2012; 61-90.
43
Doherty PC, Ferrer i Caubet L. Peter Charles Doherty: discurs llegit a la cerimònia d’investidura celebrada a la sala d’actes dela Facultat de Veterinària de la Universitat Autònoma de Barcelona el dia 2 d’octubre de l’any 2000.
44
The Manhattan Principles. https://oneworldonehealth.wcs.org/About-Us/Mission/The-Manhattan-Principles.aspx
45
Van Voorhis WC, Hooft van Huijsduijnen R, Wells TN. Profile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine. Proc Natl Acad Sci U S A 2015; 112: 15773-6.
46
Pawłowski ZS. Lord Ernest Jackson Lawson Soulsby (1926–2017) – pro memoria. Ann Parasitol 2017; 63: 361-2.
47
World health report : 2002. https://www.who.int/publications-detail-redirect/9241562072
48
World Health Organization. “One health joint plan of action (2022‒2026): working together for the health of humans, animals, plants and the environment.” (2022). https://www.who.int/publications/i/item/9789240059139
49
Home - One Earth One Ocean. https://oneearth-oneocean.com/en/
50
Vanwormer E, Conrad PA, Miller MA, Melli AC, Carpenter TE, Mazet JA. Toxoplasma gondii, source to sea: higher contribution of domestic felids to terrestrial parasite loading despite lower infection prevalence. Ecohealth 2013; 10: 277-89.
51
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217-58.
52
Dubey JP. Infectivity and pathogenicity of Toxoplasma gondii oocysts for cats. J Parasitol 1996; 82: 957-61.
53
Torrey EF, Yolken RH. Toxoplasma oocysts as a public health problem. Trends Parasitol 2013; 29: 380-4.
54
Lélu M, Villena I, Dardé ML, Aubert D, Geers R, Dupuis E, et al. Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Appl Environ Microbiol 2012; 78: 5127-32.
55
Dabritz HA, Miller MA, Atwill ER, Gardner IA, Leutenegger CM, Melli AC, et al. Detection of Toxoplasma gondii-like oocysts in cat feces and estimates of the environmental oocyst burden. J Am Vet Med Assoc 2007; 231: 1676-84.
56
Loss SR, Marra PP. Merchants of doubt in the free-ranging cat conflict. Conserv Biol 2018; 32: 265-6.
57
Levy JK, Crawford PC. Humane strategies for controlling feral cat populations. J Am Vet Med Assoc 200; 225: 1354-60.
58
Lohr CA, Lepczyk CA. Desires and management preferences of stakeholders regarding feral cats in the Hawaiian islands. Conserv Biol 2014; 28: 392-403.
59
Frenkel JK, Ruiz A, Chinchilla M. Soil survival of toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg 1975; 24: 439-43.
60
Lindsay DS, Dubey JP. Long-term survival of Toxoplasma gondii sporulated oocysts in seawater. J Parasitol 2009; 95: 1019-20.
61
Dubey JP. Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am J Vet Res 1988; 49: 910-3.
62
Holtz E. “Trap-Neuter-Return ordinances and policies in the United States: the future of animal control.” Bethesda, Maryland: Alley Cat Allies. 2014. https://anyflip.com/eccb/scvq/basic/
63
Dubey JP. A review of toxoplasmosis in wild birds. Vet Parasitol 2002; 106: 121-53.
64
Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol 2008; 38: 1257-78.
65
Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154: 357-65.
66
Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 2007; 77: 405-10.
67
Minbaeva G, Schweiger A, Bodosheva A, Kuttubaev O, Hehl AB, Tanner I, et al. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoS Negl Trop Dis 2013; 7: e2043.
68
Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep 2016; 6: 22551.
69
Dubey JP. Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis and public health significance. Zoonoses Public Health 2010; 57: 60-73.
70
İnci. Türkiye Zoonotik Hastalıklar Eylem Planı (2019-2023). Ankara; Sağlık Bakanlığı: 2019. https://vetkontrol.tarimorman.gov.tr/merkez/Belgeler/Zoonotik_Hastaliklar_Eylem_Pani.pdf
71
Halici-Ozturk F, Yakut K, Öcal FD, Erol A, Gökay S, Çağlar AT, et al. Seroprevalence of Toxoplasma gondii infections in Syrian pregnant refugee women in Turkey. Eur J Obstet Gynecol Reprod Biol 2021; 256: 91-4.
72
Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607-25.
73
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis 2011; 17: 7-15.
74
Peyron F, Mc Leod R, Ajzenberg D, Contopoulos-Ioannidis D, Kieffer F, Mandelbrot L, et al. Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches. PLoS Negl Trop Dis 2017; 11: e0005222.
75
Bobić B, Villena I, Stillwaggon E. Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings. Food Waterborne Parasitol 2019; 16: e00058.
76
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-33.
77
Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, Dardé ML, et al. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci U S A 2012; 109: 5844-9.
78
Nicolle C. Sur un protozoaire nouveau du gondi. C R Seances Acad Sci 1909; 148: 369-72.
79
Nicolle C, Manceaux LH. On a leishman body infection (or related organisms) of the gondi. 1908. Int J Parasitol 2009; 39: 863-4.
80
Sabin AB, Olitsky PK. TOXOPLASMA AND OBLIGATE INTRACELLULAR PARASITISM. Science 1937; 85: 336-8.
81
Sabin AB, Feldman HA. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science 1948; 108: 660-3.
82
Yang X, Yin X, Liu J, Niu Z, Yang J, Shen B. Essential role of pyrophosphate homeostasis mediated by the pyrophosphate-dependent phosphofructokinase in Toxoplasma gondii. PLoS Pathog 2022; 18: e1010293.
83
Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 1995; 172: 1561-6.
84
Ajzenberg D, Bañuls AL, Su C, Dumètre A, Demar M, Carme B, et al. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol 2004; 34: 1185-96.
85
Dardé ML. Genetic analysis of the diversity in Toxoplasma gondii. Ann Ist Super Sanita 2004; 40: 57-63.
86
Saeij JP, Boyle JP, Boothroyd JC. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol 2005; 21: 476-81.
87
Miller MA, Miller WA, Conrad PA, James ER, Melli AC, Leutenegger CM, et al. Type X Toxoplasma gondii in a wild mussel and terrestrial carnivores from coastal California: new linkages between terrestrial mammals, runoff and toxoplasmosis of sea otters. Int J Parasitol 2008; 38: 1319-28.
88
Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, Sibley LD. Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 2011; 41: 645-55.
89
Chaichan P, Mercier A, Galal L, Mahittikorn A, Ariey F, Morand S, et al. Geographical distribution of Toxoplasma gondii genotypes in Asia: A link with neighboring continents. Infect Genet Evol 2017; 53: 227-38.
90
Wendte JM, Gibson AK, Grigg ME. Population genetics of Toxoplasma gondii: new perspectives from parasite genotypes in wildlife. Vet Parasitol 2011; 182: 96-111.
91
Shwab EK, Zhu XQ, Majumdar D, Pena HF, Gennari SM, Dubey JP, et al. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology 2014; 141: 453-61.
92
Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992; 359: 82-5.
93
Miller MA, Grigg ME, Kreuder C, James ER, Melli AC, Crosbie PR, et al. An unusual genotype of Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is a cause of mortality. Int J Parasitol 2004; 34: 275-84.
94
Carme B, Demar M, Ajzenberg D, Dardé ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 2009; 15: 656-8.
95
Xiao J, Li Y, Prandovszky E, Kannan G, Viscidi RP, Pletnikov MV, et al. Behavioral Abnormalities in a Mouse Model of Chronic Toxoplasmosis Are Associated with MAG1 Antibody Levels and Cyst Burden. PLoS Negl Trop Dis 2016; 10: e0004674.
96
Lorenzi H, Khan A, Behnke MS, Namasivayam S, Swapna LS, Hadjithomas M, et al. Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat Commun 2016; 7: 10147.
97
Ekmen H. Toxoplasmosis’de enfeksiyon kaynakları. I. Koyun ve sığırlarda Toxoplasma antikorları. Mikrobiol Bült 1967; 1: 243-8.
98
Ekmen H. Toxoplasmosis’de enfeksiyon kaynakları, II. Köpek ve kedilerde Toxoplasma antikorları. Mikrobiol Bült. 1970; 4: 11-15.
99
Ekmen H, Altıntaş K. Bir köpekten Toxoplasma izolmanı. Türk Hij Tec Biol Derg 1973; 33: 17.
100
Yucesan B, Guldemir D, Babur C, Kilic S, Cakmak A. Whole-genome sequencing of a Toxoplasma gondii strain from a Turkish isolate using next-generation sequencing technology. Acta Trop 2021; 218: 105907.
101
Miller NL, Frenkel JK, Dubey JP. Oral infections with Toxoplasma cysts and oocysts in felines, other mammals, and in birds. J Parasitol 1972; 58: 928-37
102
Markell EK, Voge M, John DT. Other Blood-and Tissue-Dwelling Protozoa in: Medical Parasitology. WB Saunders Co; 1986.
103
Georgi, Jay R. Parasitology for veterinarians. No. 3rd edition. WB Saunders Company; 1980.
104
Berdoy M, Webster JP, Macdonald DW. Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci 2000; 267: 1591-4.
105
Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 2007; 104: 6442-7.
106
Poirotte C, Kappeler PM, Ngoubangoye B, Bourgeois S, Moussodji M, Charpentier MJ. Morbid attraction to leopard urine in Toxoplasma-infected chimpanzees. Curr Biol. 2016; 26: R98-9.
107
Work TM, Verma SK, Su C, Medeiros J, Kaiakapu T, Kwok OC, et al. TOXOPLASMA GONDII ANTIBODY PREVALENCE AND TWO NEW GENOTYPES OF THE PARASITE IN ENDANGERED HAWAIIAN GEESE (NENE: BRANTA SANDVICENSIS). J Wildl Dis 2016; 52: 253-7.
108
Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis 2011; 53: 1081-9.
109
Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003; 9: 1375-80.
110
Dabritz HA, Conrad PA. Cats and Toxoplasma: implications for public health. Zoonoses Public Health 2010; 57: 34-52.
111
Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005; 6: 41-61.
112
Hill D, Coss C, Dubey JP, Wroblewski K, Sautter M, Hosten T, et al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol 2011; 97: 328-37.
113
VanWormer E, Carpenter TE, Singh P, Shapiro K, Wallender WW, Conrad PA, et al. Coastal development and precipitation drive pathogen flow from land to sea: evidence from a Toxoplasma gondii and felid host system. Sci Rep 2016; 6: 29252.
114
Guo M, Mishra A, Buchanan RL, Dubey JP, Hill DE, Gamble HR, et al. A Systematic Meta-Analysis of Toxoplasma gondii Prevalence in Food Animals in the United States. Foodborne Pathog Dis 2016; 13: 109-18.
115
Delair E, Latkany P, Noble AG, Rabiah P, McLeod R, Brézin A. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm 2011; 19: 91-102.
116
Montoya JG, Remington JS. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis 1995; 20: 781-9.
117
Undseth Ø, Gerlyng P, Goplen AK, Holter ES, von der Lippe E, Dunlop O. Primary toxoplasmosis with critical illness and multi-organ failure in an immunocompetent young man. Scand J Infect Dis 2014; 46: 58-62.
118
McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994; 18: 38-72.
119
Ngô HM, Zhou Y, Lorenzi H, Wang K, Kim TK, Zhou Y, et al. Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. Sci Rep 2017; 7: 11496.
120
Shwab EK, Saraf P, Zhu XQ, Zhou DH, McFerrin BM, Ajzenberg D, et al. Human impact on the diversity and virulence of the ubiquitous zoonotic parasite Toxoplasma gondii. Proc Natl Acad Sci U S A 2018; 115: E6956-E6963.
121
Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, et al. Toxoplasma gondii Infection in the United States, 2011-2014. Am J Trop Med Hyg. 2018; 98: 551-7.
122
Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg 2010; 82: 464-5.
123
McLeod R, Lykins J, Gwendolyn Noble A, Rabiah P, Swisher CN, Heydemann PT, et al. Management of Congenital Toxoplasmosis. Curr Pediatr Rep 2014; 2: 166-94.
124
Ortiz S, Martin R, de Juan V. Ocular toxoplasmosis: A case report. International Journal of Clinical Medicine 2013; 4: 1-4.
125
Lykins J, Wang K, Wheeler K, Clouser F, Dixon A, El Bissati K, et al. Understanding Toxoplasmosis in the United States Through “Large Data” Analyses. Clin Infect Dis 2016; 63: 468-75.
126
Wang ZD, Liu HH, Ma ZX, Ma HY, Li ZY, Yang ZB, et al. Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis. Front Microbiol 2017; 8: 389.
127
Walker M, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 2005; 40: 1005-15.
128
Lu L, Barbi J, Pan F. The regulation of immune tolerance by FOXP3. Nat Rev Immunol 2017; 17: 703-17.
129
Chen J, Huang C, Zhu D, Shen P, Duan Y, Wang J, et al. Chinese 1 strain of Toxoplasma gondii excreted-secreted antigens negatively modulate Foxp3 via inhibition of the TGFßRII/Smad2/Smad3/Smad4 pathway. J Cell Mol Med 2017; 21: 1944-53.
130
Gao X, Zhong Y, Liu Y, Ding R, Chen J. The Role and Function of Regulatory T Cells in Toxoplasma gondii-Induced Adverse Pregnancy Outcomes. J Immunol Res 2021; 2021: 8782672.
131
de Oliveira Gomes A, de Oliveira Silva DA, Silva NM, de Freitas Barbosa B, Franco PS, Angeloni MB, et al. Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am J Pathol 2011; 178: 2792-801.
132
Barbosa BF, Paulesu L, Ietta F, Bechi N, Romagnoli R, Gomes AO, et al. Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1/2 phosphorylation and prostaglandin E2 production. Placenta 2014; 35: 152-62.
133
Kianersi F, Naderi Beni A, Ghanbari H, Fazel F. Ocular toxoplasmosis and retinal detachment: five case reports. Eur Rev Med Pharmacol Sci 2012; 16(Suppl 4): 84-9.
134
Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 2010; 128: 28-32.
135
Gajewski PD, Falkenstein M, Hengstler JG, Golka K. Toxoplasma gondii impairs memory in infected seniors. Brain Behav Immun 2014; 36: 193-9.
136
Flegr J, Prandota J, Sovičková M, Israili ZH. Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One 2014; 9: e90203.
137
Yolken RH, Dickerson FB, Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol 2009; 31: 706-15.
138
Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 2009; 197: 905-8.
139
Yereli K, Balcioğlu IC, Ozbilgin A. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci Int 2006; 163: 34-7.
140
Munoz-Zanzi CA, Fry P, Lesina B, Hill D. Toxoplasma gondii oocyst-specific antibodies and source of infection. Emerg Infect Dis 2010; 16: 1591-3.
141
Muñoz-Zanzi C, Tamayo R, Balboa J, Hill D. Detection of oocyst-associated toxoplasmosis in swine from southern Chile. Zoonoses Public Health 2012; 59: 389-92.
142
Sroka J, Wójcik-Fatla A, Dutkiewicz J. Occurrence of Toxoplasma gondii in water from wells located on farms. Ann Agric Environ Med 2006; 13: 169-75.
143
Bowie WR, King AS, Werker DH, Isaac-Renton JL, Bell A, Eng SB, et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 1997; 350: 173-7.
144
Frenkel JK, Lindsay DS, Parker BB, Dobesh M. Dogs as possible mechanical carriers of Toxoplasma, and their fur as a source of infection of young children. Int J Infect Dis 2003; 7: 292-3.
145
Bik HM, Maritz JM, Luong A, Shin H, Dominguez-Bello MG, Carlton JM. Microbial Community Patterns Associated with Automated Teller Machine Keypads in New York City. mSphere 2016; 1: e00226-16.
146
Vollaire MR, Radecki SV, Lappin MR. Seroprevalence of Toxoplasma gondii antibodies in clinically ill cats in the United States. Am J Vet Res 2005; 66: 874-7.
147
Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Vet Clin North Am Small Anim Pract 2009; 39: 1009-34.
148
Hill DE, Dubey JP. Toxoplasma gondii prevalence in farm animals in the United States. Int J Parasitol 2013; 43: 107-13.
149
Cabezón O, Millán J, Gomis M, Dubey JP, Ferroglio E, Almería S. Kennel dogs as sentinels of Leishmania infantum, Toxoplasma gondii, and Neospora caninum in Majorca Island, Spain. Parasitol Res 2010; 107: 1505-8.
150
Vesco G, Buffolano W, La Chiusa S, Mancuso G, Caracappa S, Chianca A, et al. Toxoplasma gondii infections in sheep in Sicily, southern Italy. Vet Parasitol 2007; 146: 3-8.
151
Liu YM, Zhang YY, Wang L, Wang HY, Li CH, Jiang YH, et al. Toxoplasma gondii Antibodies in Raw Milk and Sera of Cows in China. Pathogens 2022; 11: 1079.
152
Tavassoli M, Esmaeilnejad B, Malekifard F, Soleimanzadeh A, Dilmaghani M. Detection of Toxoplasma gondii DNA in Sheep and Goat Milk in Northwest of Iran by PCR-RFLP. Jundishapur J Microbiol 2013; 6: e8201.
153
Kuruca L, Belluco, S, Vieira-Pinto M, Antic, D, Blagojevic B. Current control options and a way towards risk-based control of Toxoplasma gondii in the meat chain. Food Control 2023; 146: 109556.
154
Chomel BB, Zarnke RL, Kasten RW, Kass PH, Mendes E. Serologic survey of Toxoplasma gondii in grizzly bears (Ursus arctos) and black bears (Ursus americanus), from Alaska, 1988 to 1991. J Wildl Dis 1995; 31: 472-9.
155
Oksanen A, Asbakk K, Prestrud KW, Aars J, Derocher AE, Tryland M, et al. Prevalence of antibodies against Toxoplasma gondii in polar bears (Ursus maritimus) from Svalbard and East Greenland. J Parasitol 2009; 95: 89-94.
156
Fredebaugh SL, Mateus-Pinilla NE, McAllister M, Warner RE, Weng HY. Prevalence of antibody to Toxoplasma gondii in terrestrial wildlife in a natural area. J Wildl Dis 2011; 47: 381-92.
157
Lélu M, Langlais M, Poulle ML, Gilot-Fromont E. Transmission dynamics of Toxoplasma gondii along an urban-rural gradient. Theor Popul Biol 2010; 78: 139-47.
158
Dubey JP, Dennis PM, Verma SK, Choudhary S, Ferreira LR, Oliveira S, et al. Epidemiology of toxoplasmosis in white tailed deer (Odocoileus virginianus): occurrence, congenital transmission, correlates of infection, isolation, and genetic characterization of Toxoplasma gondii. Vet Parasitol 2014; 202: 270-5.
159
Ballash GA, Dubey JP, Kwok OC, Shoben AB, Robison TL, Kraft TJ, et al. Seroprevalence of Toxoplasma gondii in White-Tailed Deer (Odocoileus virginianus) and Free-Roaming Cats (Felis catus) Across a Suburban to Urban Gradient in Northeastern Ohio. Ecohealth 2015; 12: 359-67.
160
Cole RA, Lindsay DS, Howe DK, Roderick CL, Dubey JP, Thomas NJ, et al. Biological and molecular characterizations of Toxoplasma gondii strains obtained from southern sea otters (Enhydra lutris nereis). J Parasitol 2000; 86: 526-30.
161
Dubey JP, Zarnke R, Thomas NJ, Wong SK, Van Bonn W, Briggs M, et al. Toxoplasma gondii, Neospora caninum, Sarcocystis neurona, and Sarcocystis canis-like infections in marine mammals. Vet Parasitol 2003; 116: 275-96.
162
Aguirre AA, Keefe TJ, Reif JS, Kashinsky L, Yochem PK, Saliki JT, et al. Infectious disease monitoring of the endangered Hawaiian monk seal. J Wildl Dis 2007; 43: 229-41.
163
Jensen SK, Nymo IH, Forcada J, Godfroid J, Hall A. Prevalence of Toxoplasma gondii antibodies in pinnipeds from Antarctica. Vet Rec 2012; 171: 249.
164
Johnson CK, Tinker MT, Estes JA, Conrad PA, Staedler M, Miller MA, et al. Prey choice and habitat use drive sea otter pathogen exposure in a resource-limited coastal system. Proc Natl Acad Sci U S A 2009; 106: 2242-7.
165
Shapiro K, Krusor C, Mazzillo FF, Conrad PA, Largier JL, Mazet JA, et al. Aquatic polymers can drive pathogen transmission in coastal ecosystems. Proc Biol Sci 2014; 281: 20141287.
166
Conrad PA, Miller MA, Kreuder C, James ER, Mazet J, Dabritz H, et al. Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment. Int J Parasitol 2005; 35: 1155-68.
167
Miller MA, Gardner IA, Kreuder C, Paradies DM, Worcester KR, Jessup DA, et al. Coastal freshwater runoff is a risk factor for Toxoplasma gondii infection of southern sea otters (Enhydra lutris nereis). Int J Parasitol 2002; 32: 997-1006.
168
VanWormer E, Miller MA, Conrad PA, Grigg ME, Rejmanek D, Carpenter TE, et al. Using molecular epidemiology to track Toxoplasma gondii from terrestrial carnivores to marine hosts: implications for public health and conservation. PLoS Negl Trop Dis 2014; 8: e2852.
169
Verma SK, Sweeny AR, Lovallo MJ, Calero-Bernal R, Kwok OC, Jiang T, et al. Seroprevalence, isolation and co-infection of multiple Toxoplasma gondii strains in individual bobcats (Lynx rufus) from Mississippi, USA. Int J Parasitol 2017; 47: 297-303.
170
Holshuh HJ, Sherrod AE, Taylor CR, Andrews BF, Howard EB. Toxoplasmosis in a feral northern fur seal. J Am Vet Med Assoc 1985; 187: 1229-30.
171
Inskeep W 2nd, Gardiner CH, Harris RK, Dubey JP, Goldston RT. Toxoplasmosis in Atlantic bottle-nosed dolphins (Tursiops truncatus). J Wildl Dis 1990; 26: 377-82.
172
Migaki G, Sawa TR, Dubey JP. Fatal disseminated toxoplasmosis in a spinner dolphin (Stenella longirostris). Vet Pathol 1990; 27: 463-4.
173
Jardine JE, Dubey JP. Congenital toxoplasmosis in a Indo-Pacific bottlenose dolphin (Tursiops aduncus). J Parasitol 2002; 88: 197-9.
174
Dubey JP, Lipscomb TP, Mense M. Toxoplasmosis in an elephant seal (Mirounga angustirostris). J Parasitol 2004; 90: 410-1.
175
Carlson-Bremer D, Colegrove KM, Gulland FM, Conrad PA, Mazet JA, Johnson CK. Epidemiology and pathology of Toxoplasma gondii in free-ranging California sea lions (Zalophus californianus). J Wildl Dis 2015; 51: 362-73.
176
Barbieri MM, Kashinsky L, Rotstein DS, Colegrove KM, Haman KH, Magargal SL, et al. Protozoal-related mortalities in endangered Hawaiian monk seals Neomonachus schauinslandi. Dis Aquat Organ 2016; 121: 85-95.
177
Aguirre AA, Longcore T, Barbieri M, Dabritz H, Hill D, Klein PN, et al. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. Ecohealth 2019; 16: 378-90.
178
Hinkin J, Gammon J, Cutter J. Review of personal protection equipment used in practice. Br J Community Nurs 2008; 13: 14-9.
179
Dubey JP. Toxoplasmosis of animals and humans. CRC press; 2016.
180
Gates MC. One Health continuing medical education: an avenue for advancing interdisciplinary communication on One Health issues. J Am Vet Med Assoc 2009; 234: 1384-6.
181
Dard C, Marty P, Brenier-Pinchart MP, Garnaud C, Fricker-Hidalgo H, Pelloux H, et al. Management of toxoplasmosis in transplant recipients: an update. Expert Rev Anti Infect Ther 2018; 16: 447-60.
182
Innes EA, Hamilton C, Garcia JL, Chryssafidis A, Smith D. A one health approach to vaccines against Toxoplasma gondii. Food Waterborne Parasitol 2019; 15: e00053.
183
Lundén A, Uggla A. Infectivity of Toxoplasma gondii in mutton following curing, smoking, freezing or microwave cooking. Int J Food Microbiol 1992; 15: 357-63.
184
Deng H, Exel KE, Swart A, Bonačić Marinović AA, Dam-Deisz C, van der Giessen JWB, et al. Digging into Toxoplasma gondii infections via soil: A quantitative microbial risk assessment approach. Sci Total Environ 2021; 755: 143232.
185
Zhang Y, Li D, Lu S, Zheng B. Toxoplasmosis vaccines: what we have and where to go? NPJ Vaccines 2022; 7: 131.
186
Jenkins MC. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet Parasitol 2001; 101: 291-310.
187
Brake DA. Vaccinology for control of apicomplexan parasites: a simplified language of immune programming and its use in vaccine design. Int J Parasitol 2002; 32: 509-15.
188
İnci A, Yürük M, Yıldırım A, Sohel MH, Sivcan E, Karademir GK. Toxoplasma gondii ile Deneysel Enfekte BeWo Hücre Hattında Eksozomların Karakterizasyonu. 2021. http://turkiyeparazitolojidernegi.org/wp/wp-content/uploads/2021/10/UPK22_OZET_KITABI.pdf
189
Sivcan E. Toxoplasma gondii ile enfekte insan trophoblastik hücrelerinin (BEWO) toll-like reseptör yolağına nitrofurantoinin etkisi. (dissertation). Kayseri: Erciyes Üniv. 2019.
190
Aguirre AA, Beasley VR, Augspurger T, Benson WH, Whaley J, Basu N. One health-Transdisciplinary opportunities for SETAC leadership in integrating and improving the health of people, animals, and the environment. Environ Toxicol Chem. 2016; 35: 2383-91.
191
Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 2013; 91: 501-8.
192
Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012; 139: 1375-424.
193
Gortazar C, Reperant LA, Kuiken T, de la Fuente J, Boadella M, Martínez-Lopez B, et al. Crossing the interspecies barrier: opening the door to zoonotic pathogens. PLoS Pathog 2014; 10: e1004129.
194
Suzán G, García-Peña GE, Castro-Arellano I, Rico O, Rubio AV, Tolsá MJ, et al. Metacommunity and phylogenetic structure determine wildlife and zoonotic infectious disease patterns in time and space. Ecol Evol 2015; 5: 865-73.
195
Thompson RC. Parasite zoonoses and wildlife: One Health, spillover and human activity. Int J Parasitol 2013; 43: 1079-88.
196
Massolo A, Liccioli S. Applying a One Health, multi-scale approach to understanding and preventing zoonotic parasite transmission in urban ecosystems: Echinococcus multilocularis and alveolar echinococcosis in North America; 2016.
197
Häsler B, Hiby E, Gilbert W, Obeyesekere N, Bennani H, Rushton J. A one health framework for the evaluation of rabies control programmes: a case study from Colombo City, Sri Lanka. PLoS Negl Trop Dis 2014; 8: e3270.
198
Azeez R, Prabhakar A. A review of disease inference techniques. International Journal of Science and Research 2016; 5: 514-8.
199
Vinetz JM, Wilcox BA, Aguirre A, Gollin LX, Katz AR, Fujioka RS, et al. Beyond Disciplinary Boundaries: Leptospirosis as a Model of Incorporating Transdisciplinary Approaches to Understand Infectious Disease Emergence. EcoHealth 2005; 2: 291-306.
200
Aguirre A, Wilcox BA. EcoHealth: Envisioning and creating a truly global transdiscipline. EcoHealth 2008; 5: 238-9.
201
Flegr J, Havlícek J, Kodym P, Malý M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2002; 2: 11.
202
Flegr J, Klose J, Novotná M, Berenreitterová M, Havlícek J. Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect Dis 2009; 9: 72.
203
Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol 2008; 38: 1359-70.
204
Zia-Ali N, Fazaeli A, Khoramizadeh M, Ajzenberg D, Dardé M, Keshavarz-Valian H. Isolation and molecular characterization of Toxoplasma gondii strains from different hosts in Iran. Parasitol Res 2007; 101: 111-5.
205
Mecca JN, Meireles LR, de Andrade HF Jr. Quality control of Toxoplasma gondii in meat packages: standardization of an ELISA test and its use for detection in rabbit meat cuts. Meat Sci 2011; 88: 584-9.
2024 ©️ Galenos Publishing House